Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
about
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase 2 Study of Ruxolitinib V ...... ant of Hydroxyurea (RESET-272)
@en
Phase 2 Study of Ruxolitinib V ...... o or Intolerant of Hydroxyurea
@nl
type
label
Phase 2 Study of Ruxolitinib V ...... ant of Hydroxyurea (RESET-272)
@en
Phase 2 Study of Ruxolitinib V ...... o or Intolerant of Hydroxyurea
@nl
prefLabel
Phase 2 Study of Ruxolitinib V ...... ant of Hydroxyurea (RESET-272)
@en
Phase 2 Study of Ruxolitinib V ...... o or Intolerant of Hydroxyurea
@nl
P1476
A Double-Blind, Double-Dummy P ...... ant of Hydroxyurea (RESET-272)
@en
P3098
NCT03123588
P4844
P580
2017-04-20T00:00:00Z
P582
2020-05-01T00:00:00Z